Your browser doesn't support javascript.
loading
Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia.
Bell, Hayden L; Blair, Helen J; Singh, Mankaran; Moorman, Anthony V; Heidenreich, Olaf; van Delft, Frederik W; Lunec, John; Irving, Julie A E.
Afiliação
  • Bell HL; Wolfson Childhood Cancer Research Centre, Translation and Clinical Research Institute, Newcastle University Centre for Cancer,, Newcastle Upon Tyne, UK.
  • Blair HJ; Wolfson Childhood Cancer Research Centre, Translation and Clinical Research Institute, Newcastle University Centre for Cancer,, Newcastle Upon Tyne, UK.
  • Singh M; Wolfson Childhood Cancer Research Centre, Translation and Clinical Research Institute, Newcastle University Centre for Cancer,, Newcastle Upon Tyne, UK.
  • Moorman AV; Wolfson Childhood Cancer Research Centre, Translation and Clinical Research Institute, Newcastle University Centre for Cancer,, Newcastle Upon Tyne, UK.
  • Heidenreich O; Wolfson Childhood Cancer Research Centre, Translation and Clinical Research Institute, Newcastle University Centre for Cancer,, Newcastle Upon Tyne, UK.
  • van Delft FW; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Lunec J; Wolfson Childhood Cancer Research Centre, Translation and Clinical Research Institute, Newcastle University Centre for Cancer,, Newcastle Upon Tyne, UK.
  • Irving JAE; Bioscience Institute, Newcastle University Centre for Cancer, Newcastle Upon Tyne, UK.
Cancer Cell Int ; 23(1): 202, 2023 Sep 15.
Article em En | MEDLINE | ID: mdl-37715172
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Cell Int Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Cell Int Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido